Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.Japan |
First Approval Date31 Mar 1970 |
|
MechanismSMARCA2 modulators |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Ksilink Services SAS
0 Patents (Medical) associated with Ksilink Services SAS
100 Deals associated with Ksilink Services SAS
100 Translational Medicine associated with Ksilink Services SAS